SEER Stat Fact Sheets: Bladder Cancer

Statistics at a GlanceShow More

At a Glance

  • Estimated New Cases in 2015 74,000
  • % of All New Cancer Cases4.5%
  • Estimated Deaths in 2015 16,000
  • % of All
    Cancer Deaths
    2.7%

Percent Surviving
5 Years

77.4% 2005-2011

Number of New Cases and Deaths per 100,000: The number of new cases of bladder cancer was 20.3 per 100,000 men and women per year. The number of deaths was 4.4 per 100,000 men and women per year. These rates are age-adjusted and based on 2008-2012 cases and deaths.

Lifetime Risk of Developing Cancer: Approximately 2.4 percent of men and women will be diagnosed with bladder cancer at some point during their lifetime, based on 2010-2012 data.

Prevalence of This Cancer: In 2012, there were an estimated 577,403 people living with bladder cancer in the United States.

Survival StatisticsShow More

How Many People Survive 5 Years Or More after Being Diagnosed with Bladder Cancer?

Relative survivalExternal Web Site Policy statistics compare the survival of patients diagnosed with cancer with the survival of people in the general population who are the same age, race, and sex and who have not been diagnosed with cancer. Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. No two patients are entirely alike, and treatment and responses to treatment can vary greatly.

77.4%

Percent Surviving
5 Years

77.4%

Based on data from SEER 18 2005-2011. Gray figures represent those who have died from bladder cancer. Green figures represent those who have survived 5 years or more.

Additional Information

Cancer stage at diagnosis, which refers to extent of a cancer in the body, determines treatment options and has a strong influence on the length of survival. In general, if the cancer is found only in the part of the body where it started it is localized (sometimes referred to as stage 1). If it has spread to a different part of the body, the stage is regional or distant. The earlier bladder cancer is caught, the better chance a person has of surviving five years after being diagnosed. For bladder cancer, 34.5% are diagnosed at the local stage. The 5-year survival for localized bladder cancer is 69.9%.

Percent of Cases & 5-Year Relative Survival by Stage at Diagnosis: Bladder Cancer
Percent of Cases by Stage
  • In Situ (51%)
    Only in Originating Layer of Cells
  • Localized (35%)
    Confined to Primary Site
  • Regional (7%)
    Spread to Regional Lymph Nodes
  • Distant (4%)
    Cancer Has Metastasized
  • Unknown (3%)
    Unstaged
51% in situ; 35% localized; 7% regional; 4% distant; 3% unknown
5-Year Relative Survival
95.9% in situ; 69.9% localized; 34.0% regional; 5.4% distant; 47.4% unstaged

SEER 18 2005-2011, All Races, Both Sexes by SEER Summary Stage 2000

Additional Information

Number of New Cases and DeathsShow More

How Common Is This Cancer?

Compared to other cancers, bladder cancer is fairly common.

Common Types of Cancer Estimated New
Cases 2015
Estimated
Deaths 2015
1. Breast Cancer (Female) 231,840 40,290
2. Lung and Bronchus Cancer 221,200 158,040
3. Prostate Cancer 220,800 27,540
4. Colon and Rectum Cancer 132,700 49,700
5. Bladder Cancer 74,000 16,000
6. Melanoma of the Skin 73,870 9,940
7. Non-Hodgkin Lymphoma 71,850 19,790
8. Thyroid Cancer 62,450 1,950
9. Kidney and Renal Pelvis Cancer 61,560 14,080
10. Endometrial Cancer 54,870 10,170

Bladder cancer represents 4.5% of all new cancer cases in the U.S.

4.5%

In 2015, it is estimated that there will be 74,000 new cases of bladder cancer and an estimated 16,000 people will die of this disease.

Bladder cancer becomes more common with age and is more common in men than women. The number of new cases of bladder cancer was 20.3 per 100,000 men and women per year based on 2008-2012 cases.

Percent of New Cases by Age Group: Bladder Cancer
0.1% under 20; 0.4% 20-34; 1.4% 35-44; 6.8% 45-54; 18.6% 55-64; 28.2% 65-74; 30.1% 75-84; 14.4% 85 and older

Bladder cancer is most frequently diagnosed among people aged 75-84.

Median Age
At Diagnosis

73

SEER 18 2008-2012, All Races, Both Sexes

Number of New Cases per 100,000 Persons by Race/Ethnicity & Sex: Bladder Cancer
MalesFemales
  • Male 35.8All RacesFemale 8.7
  • Male 39.0WhiteFemale 9.4
  • Male 21.4BlackFemale 6.9
  • Male 15.8Asian /
    Pacific Islander
    Female 4.0
  • Male 15.6American Indian /
    Alaska Native
    Female 3.4
  • Male 19.6HispanicFemale 5.1
  • Male 37.8Non-HispanicFemale 9.2

SEER 18 2008-2012, Age-Adjusted

Bladder cancer is the ninth leading cause of cancer death in the United States. The number of deaths was 4.4 per 100,000 men and women per year based on 2008-2012 deaths.

Percent of Deaths by Age Group: Bladder Cancer
0.0% under 20; 0.1% 20-34; 0.6% 35-44; 3.9% 45-54; 11.7% 55-64; 21.1% 65-74; 33.7% 75-84; 29.0% 85 and older

The percent of bladder cancer deaths is highest among people aged 75-84.

Median Age
At Death

79

U.S. 2008-2012, All Races, Both Sexes

Number of Deaths per 100,000 Persons by Race/Ethnicity & Sex: Bladder Cancer
MalesFemales
  • Male 7.7All RacesFemale 2.2
  • Male 8.1WhiteFemale 2.2
  • Male 5.3BlackFemale 2.5
  • Male 3.0Asian /
    Pacific Islander
    Female 0.9
  • Male 4.2American Indian /
    Alaska Native
    Female 1.1
  • Male 3.9HispanicFemale 1.3
  • Male 7.9Non-HispanicFemale 2.3

U.S. 2008-2012, Age-Adjusted

Trends in RatesShow More

Changes Over Time

Keeping track of the number of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments.

Using statistical models for analysis, rates for new bladder cancer cases have been falling on average 0.6% each year over the last 10 years. Death rates have been stable over 2002-2012. 5-year survival trends are shown below the figure.

More About This CancerShow More

Cancer and the Bladder

Anatomy of the male urinary system (left) and female urinary system (right) showing the kidneys, ureters, bladder, and urethra.
Figure: Anatomy of the male urinary system (left)
and female urinary system (right)

Click to enlarge.

The bladder is a hollow organ in the lower part of the abdomen. It is shaped like a small balloon and has a muscular wall that allows it to get larger or smaller. The urine passes from the two kidneys into the bladder through two tubes called uretersExternal Web Site Policy. The bladder is emptied through another tube called the urethra.

There are three types of bladder cancer that begin in cells in the lining of the bladder: transitional cell carcinomaExternal Web Site Policy:; squamous cell carcinomaExternal Web Site Policy; and adenocarcinomaExternal Web Site Policy.

Cancer that is confined to the lining of the bladder is called superficial bladder cancer. Cancer that begins in the transitional cells may spread through the lining of the bladder and invade the muscle wall of the bladder or spread to nearby organs and lymph nodes; this is called invasive bladder cancer.

Additional Information

More Information

Here are some resources for learning more about bladder cancer.

References

All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found within:

Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2012, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2012/, based on November 2014 SEER data submission, posted to the SEER web site, April 2015.

Suggested Citation

All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

SEER Cancer Statistics Factsheets: Bladder Cancer. National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/statfacts/html/urinb.html

This factsheet focuses on population statistics that are based on the US population. Because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. To see tailored statistics, browse the SEER Cancer Statistics Review. To see statistics for a specific state, go to the State Cancer ProfilesExternal Web Site Policy.

The statistics presented in this factsheet are based on the most recent data available, most of which can be found in the SEER Cancer Statistics Review. In some cases, different year spans may be used. Estimates for the current year are based on past data.

Cancer is a complex topic. There is a wide range of information available. This factsheet does not address causes, symptoms, diagnosis, treatment, follow-up care, or decision making, although it provides links to information in many of these areas.